Specialty vaccine company focused on prevention of infectious diseases with major unmet need, such as Lyme & chikungunya
501 - 1000
π° Post-IPO Equity on 2022-09
August 17
π‘ Remote β Anywhere in California
β° Full Time
π‘ Mid-level
π Senior